Congenital arteriovenous malformations: Tailored embolotherapy

D. M. Widlus, R. R. Murray, R. I. White, F. A. Osterman, E. R. Schreiber, R. W. Satre, S. E. Mitchell, S. L. Kaufman, G. M. Williams, A. J. Weiland

Research output: Contribution to journalArticlepeer-review

75 Scopus citations


Congenital arteriovenous malformations (AVMs) involving the pelvis or an extremity were occluded in 16 symptomatic patients, who subsequently underwent tailored embolotherapy. An additional 11 patients did not undergo embolization due to favorable vascular anatomy or lack of significant symptoms. Permanent occlusive agents including isobutyl cyanoacrylate, particles of polyvinyl alcohol foam, and coils were used to embolize the multiple feeding vessels and, when possible, the nidus of the AVM. All patients experienced dramatic reduction in pain and resolution of ulceration and bleeding, with a mean follow-up period of 41 months. Symptoms recurred in four patients, but again resolved with repeat embolization. The authors conclude that selective and repetitive embolization is highly effective in palliation of symptomatic congenital AVMs.

Original languageEnglish (US)
Pages (from-to)511-516
Number of pages6
Issue number2
StatePublished - Jan 1 1988

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Congenital arteriovenous malformations: Tailored embolotherapy'. Together they form a unique fingerprint.

Cite this